Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

681

Figures (1-6)

105

Tables (1-1)

Sum=901

Publishing Process of This Article

Item

Count

Browse

Download

129

Sum=180

Aug 15, 2024 (publication date) through Nov 9, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3397-3409
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3397

Table 1 List of c-Met inhibitors

Citation: Wei WJ, Hong YL, Deng Y, Wang GL, Qiu JT, Pan F. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review. World J Gastrointest Oncol 2024; 16(8): 3397-3409
URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3397.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3397